Related Experiment Video
Updated: Apr 18, 2026
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
3.4K
Biomarkers in cancer immunotherapy
Ton N Schumacher1, Can Kesmir2, Marit M van Buuren1
1Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
Cancer Cell
|January 14, 2015
Summary
Cancer immunotherapies targeting T cell checkpoints show promise, but limited patient response necessitates new approaches. Biomarkers and novel assay systems are being developed to improve cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Biomarker Discovery
Background:
- Cancer immunotherapies utilizing antibodies against T cell checkpoint molecules have transformed treatment paradigms.
- However, response rates to these therapies remain suboptimal, with less than half of patients benefiting.
- Identifying predictive biomarkers is crucial for optimizing patient selection and treatment strategies.
Purpose of the Study:
- To explore the potential of biomarkers in predicting patient response to cancer immunotherapies.
- To inspire the development of novel assay systems for interrogating the cancer-immunity cycle.
- To advance the understanding of factors influencing immunotherapy efficacy.
Main Methods:
- Review of recent scientific literature on cancer immunotherapy biomarkers.
- Analysis of current trends in the development of diagnostic and prognostic assays.
- Exploration of the cancer-immunity cycle and its relevance to therapeutic response.
Main Results:
- Emerging evidence suggests that specific biomarkers can predict patient outcomes in response to T cell checkpoint inhibitors.
- The development of advanced assay systems is underway to provide deeper insights into the tumor microenvironment and immune cell function.
- These advancements hold the potential to identify non-responders and guide alternative treatment strategies.
Conclusions:
- Biomarker discovery is essential for personalizing cancer immunotherapy and improving treatment efficacy.
- Novel assay systems offer promising avenues for a comprehensive understanding of the cancer-immunity axis.
- Further research is needed to translate these findings into clinically applicable tools for cancer patients.
Related Concept Videos
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
01:30Cancer Vaccines
1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K